IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
9.77
+0.23 (2.36%)
Nov 20, 2024, 4:00 PM EST - Market closed
IGM Biosciences Market Cap
IGM Biosciences has a market cap or net worth of $580.67 million as of November 21, 2024. Its market cap has increased by 84.24% in one year.
Market Cap
580.67M
Enterprise Value
407.74M
1-Year Change
84.24%
Ranking
Category
Stock Price
$9.77
Market Cap Chart
Since September 18, 2019, IGM Biosciences's market cap has decreased from $702.07M to $580.67M, a decrease of -17.29%. That is a compound annual growth rate of -3.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 580.67M | 19.66% |
| Dec 29, 2023 | 485.25M | -33.39% |
| Dec 30, 2022 | 728.48M | -23.49% |
| Dec 31, 2021 | 952.10M | -66.22% |
| Dec 31, 2020 | 2.82B | 141.87% |
| Dec 31, 2019 | 1.17B | 65.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 570.81M |
| Humacyte | 567.47M |
| Axogen | 564.14M |
| Simulations Plus | 558.37M |
| Surmodics | 558.13M |
| Standard BioTools | 552.80M |
| Alumis | 546.25M |
| Auna S.A. | 542.56M |